There have been reports of patients who have been started on peritoneal dialysis who developed CIDP shortly after. There is much that we are still learning about chronic inflammatory demyelinating ...

An initial negative peripheral blood screen for KIT D816V does not necessarily rule out a diagnosis of systemic mastocytosis. Three hundred eighty-one patients with anaphylaxis or suspected of having ...

The lifetime risk of thrombosis in patients with PNH is approximately 50%, and it tends to be found in the abdominal or cerebral veins. Patients who experience thromboses at unusual sites should be ...

Can Do MS provides free programs on topics such as nutrition, exercise, MS symptoms, relationships, and employment. Treatment for multiple sclerosis includes much more than medication and imaging.

Yiannis Papazoglou is one of only 40 people in the world with a mutation of the IRF2BPL gene. Foundation Aims to Help Patients With Rare Diseases—Even Before They’re Recognized The Undiagnosed ...

Early AATD diagnosis is crucial to prevent progressive lung damage and associated pathologies. Patients with alpha-1 antitrypsin deficiency (AATD) should be screened for vascular pathology, according ...

James Bussel, MD, is emeritus professor of pediatrics, medicine, and obstetrics and gynecology at Weill Cornell Medicine in New York City (Photo by Larry Luxner) Physicians currently treat pregnancies ...

EGPA-associated nasal polyposis should be managed with medically (ie, biologics, anti-inflammatory drugs, and topical corticosteroids) and, in some cases, surgery. Nasal polyposis associated with ...

In diagnosed cases of cutaneous mastocytosis, investigations to rule out systemic mastocytosis may be appropriate. A young child with a small chest lump and anemia was found to have cutaneous ...

Women who desire to become pregnant should be counseled on the significance of alloimmunization as a substantial risk during pregnancy. A pregnant woman with hemolytic disease of the fetus and newborn ...

The physicians observed significant improvement over the next week with epithelization rates beyond 50% by week 7. A case of a patient with a rare combination of myelofibrosis (MF) and pyoderma ...

Duration of natalizumab therapy does not appear to affect serum concentrations of the medication. Up to a 30-fold difference in natalizumab serum concentrations can occur in patients with multiple ...